SB 471-1_ Filed 02/27/2001, 10:05
The Senate Committee on Health and Provider Services, to which was referred Senate Bill No. 471, has
had the same under consideration and begs leave to report the same back to the Senate with the
recommendation that said bill be AMENDED as follows:
SOURCE: Page 1, line 1; (01)AM047103.1. -->
Page 1, delete lines 1 through 17, begin a new paragraph and insert:
SOURCE: IC 25-23-1-19.5; (01)AM047103.1. -->
, AS AMENDED BY P.L.83-2000,
SECTION 1, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2001]: Sec. 19.5. (a) The board shall establish a program
under which advanced practice nurses who meet the requirements
established by the board are authorized to prescribe legend drugs.
including controlled substances (as defined in IC 35-48-1).
(b) The authority granted by the board under this section:
(1) expires on October 31 of the odd-numbered year following the
year the authority was granted or renewed; and
(2) is subject to renewal indefinitely for successive periods of two
(c) The rules adopted under section 7 of this chapter concerning the
authority of advanced practice nurses to prescribe legend drugs must
do the following:
(1) Require an advanced practice nurse or a prospective advanced
practice nurse who seeks the authority to submit an application to
(2) Require, as a prerequisite to the initial granting of the
authority, the successful completion by the applicant of a graduate
level course in pharmacology providing at least two (2) semester
hours of academic credit.
(3) Require, as a condition of the renewal of the authority, the
completion by the advanced practice nurse of the continuing
education requirements set out in section 19.7 of this chapter.
(d) A program established under subsection (a) may not allow
an advanced practice nurse to prescribe controlled substances (as
SOURCE: ; (01)AM047103.2. -->
SECTION 2. [EFFECTIVE JULY 1, 2001] (a) As used in this
SECTION, "advisory committee" refers to the controlled
substances advisory committee established by
(b) The advisory committee shall review the records maintained
by the central repository for controlled substances designated by
the state police department under
prescribing of psychotropic medications to children.
(c) Not later than December 1, 2001, the advisory committee
shall submit a report to the legislative council, the governor, and
the medical licensing board established under
regarding the review required under this SECTION.
(d) The report required under subsection (c) must include the
(1) A comparison of the number of prescriptions written for
psychotropic medications for children:
(A) participating in Medicaid (IC 12-15) or the children's
heath insurance program (IC 12-17.6); and
(B) not participating in a program described in clause (A).
(2) A statement by the advisory committee regarding whether
the information provided under subdivision (1) indicates that
psychotropic medications are being disproportionately
prescribed for children described in subdivision (1)(A).
(3) Identification of any pattern of prescribing of psychotropic
medications for children contrary to the most recent
guidelines adopted by the American Academy of Pediatrics
and the American Academy of Child and Adolescent
(e) The report required under subsection (c) may not contain
any information that:
(1) may be used to identify a child for whom a psychotropic
medication was prescribed; or
(2) indicates that a particular physician's prescribing of
psychotropic medications to a child was inappropriate.
(f) Any meeting held by the advisory committee to comply with
this SECTION is not open to the public.
(g) Unless otherwise provided by law, records reviewed by the
advisory committee to comply with this SECTION are not public
(h) This SECTION expires December 31, 2001.
Delete page 2.
(Reference is to SB 471 as introduced.)
and when so amended that said bill do pass .
Committee Vote: Yeas 9, Nays 0.
Senator Miller, Chairperson
AM 047103/DI 104 2001